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ABSTRACT   This report is an examination of the results of the initial 200 cases that 
underwent robot assisted laparoscopic radical prostatectomy (RALP) at Kawasaki Medical 
School General Medical Center in Okayama, Japan. Two hundred patients that had RALP 
using the da Vinci Xi Surgical System from August 2016 to October 2019 were examined 
retrospectively. The median age was 70 years old, and the median PSA was 7.65 ng/ml. 
35% of the cases had received a previous abdominal surgery. RALP was performed on all 
the patients. The median surgery time was 237.5 minutes, the median console time was 173 
minutes and the median amount of bleeding was 150 ml. There were no intraoperative blood 
transfusions, complications or anastomotic failures. Histopathological examination found pT2 in 
73.0% of cases and pT3 in 26.5% with positive surgical margins in 10.3% and 50.9% of cases, 
respectively. There were 17 postoperative cases confirmed to have an inguinal hernia and 3 
cases with an incisional hernia. Also, one case had postoperative bleeding from the trocar 
insertion site, which required hemostasis and a blood transfusion. Urinary continence rates 
three months after surgery was 76.6% and was 95.3% after twelve months. RALP is a safe and 
minimally invasive method, but there are aspects that require improvement such as the pT3 
positive surgical margin rate and postoperative continence.
 doi：10.11482/KMJ-E202046181　(Accepted on November 18, 2020)
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〈Clinical Report〉
INTRODUCTION
   The da Vinci Surgical System is the most widely 
used surgical robotic system in the world. In the 20 
years since being approved for clinical use by the 
American Food and Drug Administration in the year 
2000 there have been more than 5,600 systems put 
into use worldwide. 
   In 2001, Binder et al. were the first in the world 
to perform RALP to treat prostate cancer１）, and 
since then RALP has quickly spread to replace both 
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conventional open surgeries and other laparoscopic 
surgeries. The approval of the da Vinci S in 2009 in 
Japan was much later than in some other countries 
around the world, and RALP costs have been 
covered by Japanese National Health Insurance 
since 2012. Currently RALP is a major surgical 
technique. 
   At the Kawasaki Medical School General Medical 
Center, RALP using the da Vinci Xi Surgical 
System has been performed since August 2016, and 
200 cases were performed by October 2019. In this 
report, the surgical results from those initial 200 
cases were collected and compared with the clinical 
and pathological results of other published reports. 
Our surgical methods and procedures were assessed 
to be reasonable and appropriate based on the data 
published to date.
SUBJECTS AND METHODS
   Two hundred patients underwent RALP at the 
Kawasaki Medical School General Medical Center 
in Okayama, Japan from August 2016 to October 
2019 and their cases were examined retrospectively.
   In principle, the indication for RALP was patients 
whose clinical stage was T1c-T3aN0M0, preferably 
with a performance status of 0 or 1. When patients 
had a cardiac disorder, intracranial disorder and/or 
were taking anticoagulant or antiplatelet drugs, the 
relevant physician was consulted. In general, many 
facilities halt the administration of anticoagulant 
and antiplatelet drugs before a RALP, but when the 
cessation of anticoagulants and/or antiplatelets is 
considered to be difficult, heparin is used to replace 
anticoagulants and aspirin replaces other antiplatelet 
medications. Glaucoma is often a contraindication 
for RALP at many facilities, but it is possible at our 
facility using a retroperitoneal approach in a mild 
Trendelenburg position so that intraocular pressure 
doesn’t rise. Patients with a history of abdominal 
operations were not necessarily excluded from the 
surgical indication, and a retroperitoneal approach 
was considered and chosen on a case-by-case basis.
   The surgical procedure used, with some revisions 
later added, was based on the technique reported 
by Patel et al２）. Under general anesthesia, patients 
are placed in a supine steep Trendelenburg position 
with both arms laid directly against the sides of the 
torso. An incision is made above the navel, with 
the camera port inserted into the abdominal space 
under direct vision. After inflating the abdomen to 
12 mmHg, three robot ports and two assistant ports 
are inserted (Fig. 1). The intra-abdominal pressure 
is lowered to 8 mmHg, and the patient is inclined to 
25°. The patient cart was docked to the left of the 
patient. Monopolar curved scissors were used for 
the right arm, fenestrated bipolar forceps were used 
for the left arm, and ProGrasp forceps were used 
on the extra arm. At the time of suturing, both arms 
were switched to the large needle driver. 
   The peritoneum is incised along the medial 
umbilical ligament and the prevesical space is 
revealed, then the prostatic anterior fat is removed. 
While preserving the fascia of pelvic muscle, 
the endopelvic fascia is incised close to the 
puboprostatic ligament and the dorsal vein complex 
is ligated by the border of the prostate and the 
urethra. 
   If no cancerous tissue is found in the prostate 
base biopsy, separate the gland while preserving as 
much of the bladder neck as possible. Then the vas 
deference and the seminal vesicles are exposed and 
dissected. While moving the vas deference and the 
seminal vesicles ventrally, the location of the fold 
in the Denonvillier’s fascia needs to be confirmed. 
When preserving the nerves, the posterior wall of 
the prostate is dissected at the ventral layer of the 
Denonvillier’s fascia, while the posterior wall of the 
prostate is dissected at the layer of fat of the anterior 
wall of the rectum when not preserving the nerves.
   When preserving the nerves, lateral pedicles are 
clipped with the Hem-o-lok clip (Weck Closure 
Systems, Research Triangle Park, NC), and when 
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not preserving the nerves, the lateral pedicles are cut 
with a Ligasure Vessel Sealing System (Covidien, 
Boulder, Colo) or an electric knife. After setting the 
pneumoperitoneum pressure to 15 mmHg to avoid 
venous bleeding, the ligated dorsal vein complex 
is lifted ventrally to keep the border between the 
urethra and the prostate clear. The dorsal vein 
complex is divided away from the ligature and the 
anterior urethra is exposed and the margins of the 
dorsal vein complex are closed up with a continuous 
suture. After suturing, the pneumoperitoneum 
pressure is set back to 8 mmHg. If no cancerous 
tissues are found in the apex, the urethra is 
disconnected as proximally as possible to leave 
more urethral stump. The removed specimen is 
stored in an endopouch and lymph node dissection 
is performed after stanching the bleeding. The 
posterior reconstruction is done with two layers, 
followed by vesicourethral anastomosis and anterior 
reconstruction. The indwelling drainage catheter 
is left after undocking. The endopouch is retrieved 
after the patient is moved from the Trendelenburg 
position to a level position and the port opening is 
sutured. 
   To manage postoperative pain, fentanyl is 
continuously administered only during the operation 
day. The basic principle is to start walking and 
eating from the first day after surgery, to remove 
the drainage tube on the third day and the urethral 
catheter on the sixth day. Depending on the patient’s 
condition, the schedule can be changed according to 
the decisions of the chief surgeon.
   The cases were evaluated based on the patients’ 
background, surgical results, pathological findings, 
postoperative complications and continence results.
   The study protocol was approved by the Ethical 
Committee of Kawasaki Medical School (Approval 
No. 5012-00).
RESULTS
   Of the RALPs performed between August 2016 to 
October 2019, 200 cases were deemed as suitable 
for evaluation. Table 1 indicates the patients’ 
background. The ages ranged from 50 to 81 years 
old (median: 70 y.o.), the preoperative PSA was 
2.8-98 ng/ml (median: 7.65 ng/ml). 70 cases (35%) 
had a history of abdominal surgery, but no cases 
required a conversion to laparotomy. 10 cases (0.5%) 
had glaucoma and 15 cases (7.5%) had a history of 
brain disease. 32 cases (16%) received preoperative 
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endocrine therapy for various reasons. The clinical 
diagnosis was T2 for 80% of the cases. D’Amico 
risk classification showed the majority (122 cases, 
61%) were in the high-risk group. 
Table 1. Demographic data
No. of pts 200
median (range)
Age, yrs 70 (50-81)
Body Mass Index 24.1 (16.9-34.5)
PSA (ng/ml) 7.65 (2.8-98.0)
Prostate volume (cm3) 28 (12-108)
Previous abdominal surgery, pts 70 35.0%
Appendectomy 32 16.0%
Inguinal hernia 19 9.5%
Cholecystectomy    10 5.0%
Gastrectomy  7 3.5%
Colectomy 2 1.0%
Previous hormonal therapy, pts 32 16.0%
Gleason score, pts GS ≦６ 38 19.0%
GS  =７ 74 37.0%
GS ≧ 8 88 44.0%





D’Amico risk stratification, pts low 22 11.0%
intermediate 56 28.0%
high 122 61.0%
Table 2. Operative results
 median (range)
Operation time, min 237.5 (172-345)
Console time, min 173 (114-285)
Blood loss including urine, ml 150 (20-900)
Hemoblobin level, mg/dl
　pre-operative 14.6 (11.0-17.9)
　post-operative 12.6  (7.2-16.9)








Lymphnode dissection 51 25.50%
Intraoperative allogenic transfusion 0 0%
Intraoperative complications, pts 0 0%
Open conversion, pts 0 0%
Catheterization period, days 6 (5-9)
urinary leakage 0 0%
Hospitalization period, days 10 (8-22)
   Table 2 shows the surgical results. The surgery 
time ranged 172-345 minutes (median: 237.5 
minutes), the console usage time was 114-285 
minutes (median: 173 minutes) and blood loss 
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Table 3. Pathological results
No. of pts (%) RM positive
Pathological stage overall 43 21.5%
　　　　　　　pT2 146 73.0% 15 10.3%
pT2a 24 12.0% 0 0.0%
pT2b 16 8.0% 2 12.5%
pT2c 106 53.0% 13 12.3%
　　　　　　　pT3 53 26.5% 27 50.9%
pT3a 35 17.5% 16 45.7%
pT3b 18 9.0% 11 61.1%
　　　　　　　pT4 1 0.5% 1 100.0%
Gleason score GS ≦ 6 26 13.0% 3 11.5%
GS =7 111 55.5% 18 16.2%
GS ≧ 8 63 31.5% 22 34.9%









Table 5. Postoperative continence
1 month 44.9% (89/198)
3 months 76.6% (151/197)
6 months 90.3% (178/197)
12 months 95.3% (163/171)
Chyle Leak 1
※ Definition of continence: no pads or 1 pad per day (safety pad)
including urine varied 20-900 ml (median: 150 
ml). A retroperitoneal approach was used in 18 
cases (9.0%) due to a history of abdominal surgery, 
intracranial disease, or glaucoma. Bilateral nerve-
sparing was performed in 35 (17.5%), unilateral 
in 46 (23.0%) and none in 119 cases (59.5%). No 
cases required a blood transfusion and there were 
no complications during surgery. The period of the 
catheterization was 5-9 days (median: 6 days), and 
the period of hospitalization was 8-22 days (median: 
10 days). There were no cases in which anastomosis 
failure caused the extravasation of urine.
   Table 3 shows the histopathological findings. 
There were 146 cases with pT2 (73.0%), 53 cases 
with pT3 (26.5%), and 1 case with pT4 (0.5%), with 
a positive surgical margin in 15 (10.3%), 27 (50.9%) 
and 1 case (100%), respectively. Among the pT2a 
cases there were no cases with a positive surgical 
margin. When compared with the patient’s Gleason 
scores, the percentage of positive surgical margins 
rose along with the Gleason score. Lymph node 
dissection was done in 51 cases, with 5 of those 
cases being classified as pN1.
   Table 4 shows postoperative complications. 
During observation, 17 patients developed an 
inguinal hernia and 3  patients developed an 
incisional hernia. Also, 2 patients had a wide range 
of subcutaneous bleeding a week after surgery. One 
patient had postoperative bleeding from the trocar 
insertion site, which required stanching and a blood 
transfusion. 
   Table 5 shows the progress of postoperative 
continence. Continence was defined as requiring 
no pad or just one pad a day as a safety pad. The 
continence rates after surgery were 44.9% a month 
after surgery, 76.6% three months after surgery, 
90.3% six months after surgery and 95.3% twelve 
months after surgery. A high continence rate was 
observed a year after the surgery even while a 
small number of patients continued to have severe 
incontinence.
DISCUSSION
   RALP was approved and covered by the Japanese 
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National Health Insurance in 2012, and the types 
of robot-assisted surgeries performed in Japan in 
urology as well as in various other fields has been 
growing. Among urological robot assisted surgeries, 
a partial nephrectomy to treat kidney cancer was 
first approved in Japan in 2016, a total cystectomy 
in 2018 and pyeloplasty was approved in 2020.
   At our facility from August 2016 to October 
2019, 200 cases met the indications for RALP, 
and no cases needed to be switched to a different 
surgical method. The existing reports at the time 
stated that RALP could be safely performed on 
patients without damaging oncological or functional 
effects in patients with a history of abdominal 
surgery３，４）. Over a third (35%) of our patients 
had a history of abdominal surgery mainly for an 
appendicitis or an inguinal hernia, but none of them 
required a conversion to open surgery. RALP was 
safely performable just as the existing reports had 
described.
Another notable concern was the possibility that a 
steep Trendelenburg position can negatively affect 
a patients’ circulatory dynamics, brain pressure 
and intraocular pressure５）. Our patients with a 
history of glaucoma or intracranial diseases were 
0.5% and 7.5%, respectively, and a retroperitoneal 
approach was chosen for those cases to avoid the 
steep Trendelenburg position. As a result, there 
were no postoperative problems related to glaucoma 
or intracranial disease, and it can be stated that 
RALP is not necessarily contraindicated even when 
patients have such a history. A meta-analysis by 
Tang et al６）. stated a broad surgical time range of 
140-280 minutes. Our surgical time range of 172-
345 minutes (median: 237.5 minutes) tended to 
be a little longer than those previously published 
reports possibly due to the time taken to staunch 
and suture places that are bleeding. The use of a 
hemostatic agent could be one option to shorten our 
surgical time. The reported amount of intraoperative 
bleeding according to multiple reports was between 
150 to 400 ml６，７）, which is similar to our results 
of 20-900 ml (median: 150 ml). As a result, there 
were no cases that required an intraoperative blood 
transfusion. Our catheterization period was similar 
to published reports８） and there were no cases of 
anastomotic failure, thus it can be concluded that 
our procedures and methods in those areas do not 
have problems either.
   Tewari et al. reported７） that the frequencies of 
intraoperative and perioperative complications 
were as follows: 0.9% requiring further surgeries, 
0.8% with an intestinal obstruction, 0.7% with 
hematoma, 0.7% developing a wound infection, 
0.3% with rectal damage, 0.3% developing deep 
vein thrombosis, 0.3% with a pulmonary embolism, 
0.2% having a cardiac infarction, 0.09% with 
digestive system damage, 0.05% with pneumonia, 
and a 0.04% mortality rate. One of our cases 
had bleeding from the trocar insertion site after 
surgery and required another surgery. To minimize 
complications, careful attention is necessary to 
confirm that there is no bleeding or digestive tract 
damage. The published literature showed a small 
percentage (0.3%) with a pulmonary embolism 
caused by deep vein thrombosis, but this did not 
occur among our cases７）. RALP with the da Vinci 
Xi Surgical System does not require patients to 
be in the lithotomy position, so fewer embolisms 
are likely to occur. However, it is still necessary to 
minimize possible risk factors such as attempting to 
shorten the surgical time and to avoid compression 
of pelvic veins by the system’s instrument shafts. 
Our understanding is that lowering the intra-
abdominal pressure as much as possible decreases 
the risk of deep vein thrombosis, therefore our 
procedure is to keep the pressure at 8 mmHg when 
possible. 
   Alder et al９）. reported that the estimated incidence 
of inguinal hernia after RALP was 7.9% and 
intraoperative inguinal hernia prevention techniques 
significantly improved the inguinal hernia incidence. 
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In this report, 17 cases (8.5%) developed inguinal 
hernias within 3 years after surgery. As of now, we 
don’t perform any procedure to prevent inguinal 
hernia because no reliable procedures exist. We 
should consider more reliable prevention techniques 
in the near future. 
   Past reports６－８，10，11） stated a positive surgical 
margin in 8-12% of pT2 cases and around 40% in 
pT3 cases. Our pT3 cases had a higher percentage 
of positive surgical margin (50.9%). Preoperative 
MRIs and biopsies are used for tumor localization 
for pT3 cases and expanding the resection margin 
may reduce the incidence of positive surgical 
margin. Thus, the resection line should be adjusted 
to suit each case. The follow-up term in this report is 
short so biochemical recurrence was not examined 
but needs to be evaluated in the future along with 
further monitoring of our positive surgical margin 
rate.
   Urinary continence in this report was defined as 
requiring no pad or just one pad a day as a safety 
pad. Alexander et al８）. reported that 21.8% didn’t 
use any pads a week after surgery and 30.9% used 
just a single pad, 78.4% didn’t use any pads or only 
used a safety pad 3 months after surgery, and 90.3% 
didn’t use any a year after surgery. Definitions of 
continence vary among professionals and different 
reports are very challenging to directly compare. 
That being said, our 12 months continence results 
seem to be equivalent to other published results, 
even though our early postoperative recovery seems 
comparatively worse. There are cases that do not 
regain continence even a year after surgery. In this 
report, only less than 50% of the cases underwent 
nerve-sparing, so actively choosing surgical methods 
such as bilateral nerve preservation or Retzius space 
preservation12，13） can begin to improve surgical 
results. If so, it is important to consider each case 
carefully and balance the methods that might reduce 
positive surgical margin with methods that might 
improve long-term incontinence. 
   In a report８） that compared RALP and retropubic 
radical prostatectomies, RALP was proved to be 
superior in terms of intraoperative bleeding, blood 
transfusions and the period of urinary catheter 
indwelling, but there was no significant difference 
in terms of positive surgical margin or biochemical 
recurrence. The RALP group showed just a slight 
superiority in terms of urinary continence, and there 
was no difference in sexual function found between 
the two groups. In that report, the authors did not 
state that either method was superior, but instead 
concluded that the most important factor is the 
surgeon’s skill. 
   Novara et al11，14）. reported that RALP was superior 
in terms of bleeding and blood transfusions but there 
was no difference between the two methods in terms 
of positive surgical margin. On the other hand, Tang 
et al６）. reported that RALP is superior in terms of 
positive surgical margin, biochemical recurrence, 
and sexual function. These conflicting reports make 
it difficult to make a conclusion on superiority. 
Both surgical methods can indeed be effective 
if performed by a skillful surgeon. However, in 
Japan there are not a sufficient number of cases 
at many facilities that would allow a surgeon to 
become an experienced expert in retropubic radical 
prostatectomy. Recently RALP has been reported 
to have a shorter learning curve15，16）, thus giving 
RALP an advantage to become the standard method 
in the future. 
CONCLUSION
   RALP has twenty years of history around the 
world and its surgical techniques have largely been 
standardized. However, there yet remain some 
issues to be solved such as frequent postoperative 
inguinal hernias, the necessity of extended pelvic 
lymph node dissection and refractory urinary 
incontinence. Although our experiences here had 
similar results to published reports, there are aspects 
of our techniques and methods that can be improved 
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in the future.
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